STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Neurovive Pharmaceutical (STO:NVP):
Third Quarter (1 July 2015 – 30 Sept. 2015)
· Net revenues were SEK 0 (7,152,000) and other operating income was SEK 74,000 (2,000).
Help employers find you! Check out all the jobs and post your resume.
